(Total Views: 336)
Posted On: 05/20/2019 6:09:16 PM
Post# of 72440
Re: aragon1959 #56765
Kevetrin P1 QofL (I take that to mean Quality of LIfe) was outstanding - terminal patients and none experienced any serious side effects. Drug was so safe they terminated trial since increased dosage provided no added efficacy and they couldn't reach any terminal end points as to negative side effects.
What other cancer drug working with any cancer patients, much less terminal patients that are in the most fragile state of being, have you heard of that didn't reach any negative physical end points?
This fact alone should have ramped Kevetrin to a platform position in the world of cancer research, especially when it showed the potential to be a complementary star when working with most other current cancer treatments. Case in point, the reduction of tumors in renal cancer(?) where no reductions prior had ever been seen.
Makes me wonder why so many bright doctors didn't figure this out?
What other cancer drug working with any cancer patients, much less terminal patients that are in the most fragile state of being, have you heard of that didn't reach any negative physical end points?
This fact alone should have ramped Kevetrin to a platform position in the world of cancer research, especially when it showed the potential to be a complementary star when working with most other current cancer treatments. Case in point, the reduction of tumors in renal cancer(?) where no reductions prior had ever been seen.
Makes me wonder why so many bright doctors didn't figure this out?
(2)
(0)Scroll down for more posts ▼
